ALOXI

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug ALOXI contains one active pharmaceutical ingredient (API):

1 Palonosetron
UNII 23310D4I19 - PALONOSETRON HYDROCHLORIDE

Palonosetron is a selective high-affinity receptor antagonist of the 5HT3 receptor.

Read about Palonosetron

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ALOXI Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
ALOXI Soft capsule European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A04AA05 Palonosetron A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AA Serotonin (5HT3) antagonists
Discover more medicines within A04AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 5295Q, 5853C
Country: CA Health Products and Food Branch Identifier(s): 02381710, 02381729
Country: EE Ravimiamet Identifier(s): 1208911, 1476963, 1476974
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 04306001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 068014, 158992, 177320
Country: FR Base de données publique des médicaments Identifier(s): 61794949
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 201362, 95212
Country: HK Department of Health Drug Office Identifier(s): 57102, 62549, 62573
Country: JP 医薬品医療機器総合機構 Identifier(s): 2391404A1020, 2391404G1022
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1027356, 1056104, 1056105
Country: NL Z-Index G-Standaard, PRK Identifier(s): 98477
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11833
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100136481, 100276650
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W43177001, W56568001, W56568002
Country: SG Health Sciences Authority Identifier(s): 14038P, 15293P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699650772065
Country: US FDA, National Drug Code Identifier(s): 69639-103, 69639-104

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.